CYCLOPHARM LIMITED — Director's Dealing 2007

Feb 11, 2007

Rule 3.19A.1

Appendix 3X

Initial Director's Interest Notice

	Name of entity CYCLOPHARM LIMITED
ABN	74 116 931 250

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Bernard Claude Salin
Date of appointment	01/09/2006

Part 1 - Director's relevant interests in securities of which the director is the registered holder

Number & class of securities Ordinary Shares	Nil
Direct:	Nil

$\overline{\text{+ See chapter 19}}$ for defined terms.

Part 2 – Director's relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest		Number & class of Securities
Hua Wang Bank Berhad (Nominee) ۰	Ordinary Shares	240,689
Indirect		240,689
Total (Direct & Indirect):		240,689

Part 3 – Director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	Nil
Nature of interest
Name of registered holder (if issued securities)
No. and class of securities to which interest relates

⁺ See chapter 19 for defined terms.